Glycobiology, 2000, Vol. 10, No. 12 1277-1281
© 2000 Oxford University Press
Defect in N-glycosylation of proteins is tissue-dependent in Congenital Disorders of Glycosylation Ia
2Biochimie A, Hôpital Bichat, 75877 Paris cedex 18, France, 3Service de Pédiatrie et maladies métaboliques, 4Service de Génétique Médicale, INSERM U393, Hôpital Necker, 75743 Paris cedex 15, France, 5INSERM U504, 94807 Villejuif cedex, France, 6Faculté de Pharmacie, Université Paris XI, 92260 Châtenay-Malabry cedex, France, and 7Faculté de Pharmacie, Université Paris V, 75270 Paris cedex 06, France
The biochemical hallmark of Congenital Disorders of Glycosylation (CDG) including type Ia is a defective N-glycosylation of serum glycoproteins. Hypoglycosylated forms of
1-antitrypsin have been detected by Western blot in serum from CDG Ia patients. In contrast we were not able to detect hypoglycosylation in
1-antitrypsin synthesized by fibroblasts, keratinocytes, enterocytes, and leukocytes. Similarly no hypoglycosylation was detectable in a membrane-associated N-linked glycoprotein, the facilitative glucose transporter GLUT-1 and also in serum immunoglobulin G isolated from sera of CDG Ia patients. We conclude that the phenotypic expression of CDG Ia is tissue-dependent.
1 To whom correspondence should be addressed at: Laboratoire de Biochimie A Hôpital BichatClaude Bernard, 46 rue H. Huchard, 75877 Paris cédex 18, France
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
N. Gao, J. Shang, and M. A. Lehrman Analysis of Glycosylation in CDG-Ia Fibroblasts by Fluorophore-assisted Carbohydrate Electrophoresis: IMPLICATIONS FOR EXTRACELLULAR GLUCOSE AND INTRACELLULAR MANNOSE 6-PHOSPHATE J. Biol. Chem., May 6, 2005; 280(18): 17901 - 17909. [Abstract] [Full Text] [PDF] |
||||
![]() |
J. Shang and M. A. Lehrman Metformin-stimulated Mannose Transport in Dermal Fibroblasts J. Biol. Chem., March 12, 2004; 279(11): 9703 - 9712. [Abstract] [Full Text] [PDF] |
||||
![]() |
M. Butler, D. Quelhas, A. J. Critchley, H. Carchon, H. F. Hebestreit, R. G. Hibbert, L. Vilarinho, E. Teles, G. Matthijs, E. Schollen, et al. Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis Glycobiology, September 1, 2003; 13(9): 601 - 622. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Callewaert, E. Schollen, A. Vanhecke, J. Jaeken, G. Matthijs, and R. Contreras Increased fucosylation and reduced branching of serum glycoprotein N-glycans in all known subtypes of congenital disorder of glycosylation I Glycobiology, May 1, 2003; 13(5): 367 - 375. [Abstract] [Full Text] [PDF] |
||||
![]() |
Y. Wang, J. Tan, M. Sutton-Smith, D. Ditto, M. Panico, R. M. Campbell, N. M. Varki, J. M. Long, J. Jaeken, S. R. Levinson, et al. Modeling human congenital disorder of glycosylation type IIa in the mouse: conservation of asparagine-linked glycan-dependent functions in mammalian physiology and insights into disease pathogenesis Glycobiology, December 1, 2001; 11(12): 1051 - 1070. [Abstract] [Full Text] [PDF] |
||||

